OEM Monitoring Technology Solutions

Nellcor™ cardiac-based pulse oximetry delivers accurate and trusted SpO2 and respiratory monitoring for patients at all acuity levels. It provides:

• LoSat accuracy range 60% to 100% SpO2
• SatSeconds clinician-controlled alarm management tools
• Saturation Pattern Detection (SPD) Alert
• Motion-tolerant oximetry performance*
• Respiration Rate software for affordable, noninvasive monitoring of respiratory status – all from a single sensor

Designed for accuracy, Microstream™ technology uses CO2-specific Molecular Correlation Spectroscopy™ (MCS) and Uni-junction sampling line technology to deliver clear, crisp waveforms and accurate etCO2 and respiration rate measurements.

Engineered for use on both intubated and non-intubated patients, Microstream™ technology with its broad portfolio of patient-interface solutions can be used with virtually all patient populations and clinical environments. And, the Smart Capnography™ suite of algorithms are proven to reduce alarms and/or simplify the use of capnography monitoring, including: Smart Breath Detection™, Smart Alarm for Respiratory Analysis™ (SARA™), Integrated Pulmonary Index™ (IPI) algorithm and the new Apnea-Sat Alert™ algorithm.

Indicated for patients of any age or weight, INVOS™ cerebral/somatic oximetry provides real-time measurement and display of regional oxygen saturation (rSO2) in the vasculature beneath the sensor, to help clinicians assess site-specific adequacy of perfusion in the brain and vital organ areas.

The clinical standard in regional oximetry, the INVOS™ system is the only cerebral/somatic oximeter with rigorous, peer-reviewed clinical investigations (more than 600) and the demonstrated ability to improve patient outcomes.

Using EEG signals and the scientifically validated Bispectral Index™ technology, also known as BIS™ technology. BIS™ brain monitoring helps clinicians customise anaesthetic dosing to individual physiologies in every phase of anaesthesia.

BIS™ technology is the most widely studied and published of its kind, and is proven to improve anaesthesia-related clinical outcomes. It has FDA cleared indications for helping reduce awareness and anaesthetic consumption. With advanced bilateral features and 4-channel EEG monitoring, BIS brain monitoring technology provides the capability to detect hemispheric differences in the brain.